Evidence-based · Written by Dr. Leila Fazlicic, D.Ac, L.Ac · All key claims cited to peer-reviewed research
The short answer: Observational studies of women trying to conceive, couples in IVF, and men's semen quality fairly consistently associate higher Mediterranean-diet adherence with better fertility outcomes — but association is not causation: randomized trials are almost nonexistent, at least one well-run cohort found no clear benefit, and no diet can guarantee a pregnancy. It remains a reasonable, low-risk default eating pattern for both partners in the months before trying to conceive or starting a cycle.
Here is the Mediterranean diet fertility evidence, reviewed study by study — women, men, natural conception, and IVF.
If you have spent any time in fertility forums, you have seen the Mediterranean diet presented as settled science — sometimes as a near-treatment. I want to do something different here: walk through what the Mediterranean diet fertility research actually says, study by study, with the numbers, the designs, and the honest limitations. The evidence is genuinely encouraging and genuinely incomplete, and you deserve to know both.
Does the Mediterranean diet improve fertility?
The most precise answer the literature supports: greater adherence to a Mediterranean-style pattern — high in vegetables, fruit, legumes, whole grains, fish, olive oil, and nuts; low in processed meat, refined grains, and added sugar — is associated with better fertility outcomes in multiple observational cohorts, for both women and men. Whether the diet causes those outcomes has never been tested in a large randomized trial.
That distinction is the central fact of this literature. In a 2018 review, Harvard researchers Audrey Gaskins and Jorge Chavarro concluded that "adherence to healthy diets favoring seafood, poultry, whole grains, fruits, and vegetables are related to better fertility in women and better semen quality in men" — while naming the biggest gaps: the most consistent findings have not been tested in randomized trials, and almost no studies consider both partners' diets together (Gaskins & Chavarro, 2018). So the Mediterranean diet sits on a stack of consistent, biologically plausible, but largely observational evidence. Let's take each population separately.
What does the research show for women trying to conceive naturally?
The largest dataset on diet and natural conception comes from the Nurses' Health Study II, which followed 17,544 women without a history of infertility for eight years. Chavarro and colleagues built a "fertility diet" score — not identical to a Mediterranean score, but overlapping substantially: monounsaturated rather than trans fats, more vegetable protein, lower-glycemic carbohydrates. Women in the highest quintile of adherence had a multivariable-adjusted relative risk of ovulatory disorder infertility of 0.34 (95% CI 0.23–0.48) versus the lowest quintile — roughly a 66% lower risk (Chavarro et al., 2007).
That striking number deserves a careful reading. First, it applies specifically to ovulatory disorder infertility — not to infertility from blocked tubes, endometriosis, diminished ovarian reserve, or male factor. Diet plausibly influences ovulation through insulin and hormonal pathways; it cannot reopen a fallopian tube. Second, this was a prospective cohort of self-reported diet. Women who eat this way differ in dozens of measured and unmeasured ways — income, exercise, smoking, sleep, healthcare access — and no statistical adjustment fully removes that residual confounding. Still, the direction and consistency of findings across cohorts is why most researchers consider a Mediterranean-style pattern a sensible foundation for women trying to conceive, particularly where ovulation is part of the picture.
What does Mediterranean diet fertility research show for IVF outcomes?
This is where the Mediterranean diet fertility literature gets specific — and where the honest complications live. Four cohort studies anchor the conversation; they do not all agree.
Vujkovic 2010: the Rotterdam couples study
The earliest anchor study followed 161 Dutch couples undergoing IVF or ICSI in Rotterdam. High adherence by the couple — both partners — to a "Mediterranean" pattern (high vegetable oils, vegetables, fish, and legumes; low snacks) was associated with increased probability of pregnancy: odds ratio 1.4 (95% CI 1.0–1.9). The pattern also correlated with higher red blood cell folate and vitamin B6 in blood and follicular fluid, a biomarker-level hint at mechanism (Vujkovic et al., 2010).
Limitations worth naming: 161 couples is small; the confidence interval touches 1.0, so the result sits at the edge of statistical significance; and the dietary patterns were derived from this specific population, making exact replication difficult. What the study did well — and what makes it unusual even now — is treating the couple, not the woman alone, as the unit of analysis.
Karayiannis 2018: the Athens cohort and the age split
The most-quoted numbers in this field come from a prospective cohort of 244 non-obese women (ages 22–41) undergoing a first IVF cycle in Athens, scored with the validated MedDietScore. Compared with the highest adherence tertile, women in the lowest tertile had significantly lower rates of clinical pregnancy (29.1% vs 50.0%) and live birth (26.6% vs 48.8%); the adjusted relative risk of live birth for lowest versus highest was 0.32 (95% CI 0.14–0.71) (Karayiannis et al., 2018).
Now the detail that headlines routinely drop: the association was significantly modified by age. The benefit was concentrated in women under 35 — in that group, each 5-point increase in MedDietScore was associated with roughly 2.7 times higher likelihood of clinical pregnancy and live birth. In women 35 and older, there was no significant association. The authors are candid about their study's boundaries: findings cannot be generalized to obese women or other populations, and "due to the observational study design, causal inference is limited." Notably, the diet score was not associated with any intermediate outcome — oocyte yield, fertilization rate, embryo quality — a puzzle if you expect a straightforward pathway from diet to eggs to babies.
One interpretation: in older patients, oocyte aging may be a stronger determinant of outcome than anything diet can shift within one cycle. That is speculative, but it fits the broader principle that egg quality reflects both age and the daily environment eggs mature in — diet is one input among many, not an override switch.
Ricci 2019: the null result you should also know about
An evidence review that only shows the positive studies is marketing. Here is the other side: an Italian prospective cohort of 474 women undergoing IVF (mean age 36.6) found Mediterranean diet score not significantly associated with embryo transfer, clinical pregnancy, or live birth after adjustment. The authors are blunt: "No clear association was observed between adherence to a Mediterranean diet and successful in vitro fertilization" (Ricci et al., 2019). One subgroup showed a marginal benefit, but with a confidence interval touching 1.0 amid many subgroup tests, that is thin ice.
Why might Ricci differ from Karayiannis? The Italian cohort was older — and the Greek benefit appeared only under 35. There is also a ceiling problem: baseline adherence in Italy is high, so the "low adherence" group may still eat fairly well, compressing the contrast. Both explanations are plausible; neither is proven.
Gaskins 2019: the EARTH study comparison
A Harvard team followed 357 women through 608 ART cycles and compared four dietary patterns head-to-head. Women in quartiles 2–4 of Mediterranean adherence had a higher probability of live birth (0.44 vs 0.31 in the lowest quartile) — but there was no dose-response above the second quartile, and a purpose-built "profertility diet" outperformed it, with 53% higher adjusted odds of live birth per standard deviation of adherence (Gaskins et al., 2019). Translation: avoiding a poor-quality diet mattered; Mediterranean perfectionism added little; and a pattern tuned to fertility-specific evidence did better still in this American cohort.
| Study | Population | Key finding | Main limitation |
|---|---|---|---|
| Vujkovic 2010 (Fertil Steril) | 161 Dutch couples, IVF/ICSI | Couple's high MedDiet adherence: OR 1.4 (95% CI 1.0–1.9) for pregnancy; higher RBC folate and B6 | Small; CI touches 1.0; observational |
| Karayiannis 2018 (Hum Reprod) | 244 non-obese Greek women, first IVF | Live birth 48.8% (top tertile) vs 26.6% (bottom); benefit only in women <35 | Observational; no effect on egg/embryo measures; not generalizable to obese women or age ≥35 |
| Ricci 2019 (AJOG) | 474 Italian women, IVF, mean age 36.6 | No clear association between MedDiet score and pregnancy or live birth | Older cohort; high baseline adherence may compress contrast |
| Gaskins 2019 (AJOG, EARTH) | 357 US women, 608 ART cycles | Live birth 0.44 vs 0.31 (MedDiet Q2–4 vs Q1); no dose-response; "profertility diet" performed better | Observational; single fertility center; diet self-reported |
| Karayiannis 2017 (Hum Reprod) | 225 Greek men, fertility clinic | Lowest MedDiet tertile: ~2.6× higher odds of abnormal sperm concentration, count, and motility | Cross-sectional — cannot determine causality; semen parameters, not pregnancies |
| Muffone 2023 (Nutr Rev, meta-analysis) | 11 cohort studies; 13,157 women, 1,338 men | Signals for sperm parameters and pregnancy, but pooled results inconsistent (I² up to 94%) | High heterogeneity; authors judge evidence insufficient for clinical application |
Does the Mediterranean diet improve sperm quality?
Fertility nutrition content routinely writes men out of the story — even though male factors contribute to a substantial share of infertility, and sperm influence embryo quality, implantation, and miscarriage risk, not just fertilization.
The anchor study here is the male-partner arm of the Athens cohort: 225 men attending a fertility clinic, assessed with the same MedDietScore. The contrasts were large. Comparing the lowest adherence tertile with the highest, the proportion falling below WHO reference values was 47.4% vs 16.7% for sperm concentration, 55.3% vs 22.7% for total count, and 65.8% vs 31.8% for total motility; after adjustment, the lowest tertile had roughly 2.6 times higher odds of abnormal concentration, count, and motility (Karayiannis et al., 2017).
The critical limitation is in the study's own text: it is cross-sectional. Diet and semen were measured at the same time, so we cannot say the diet produced the sperm quality — and the authors add a caveat that matters even more: "Whether this translates into differences in male fertility remains to be elucidated." Semen parameters are a surrogate outcome; better numbers do not automatically mean more live births.
Zooming out, a systematic review in Human Reproduction Update examined 35 observational studies of diet and male fertility. The pattern was consistent: diets rich in fish and seafood, vegetables, fruits, whole grains, and omega-3s were associated with better semen quality; patterns heavy in processed meat, sugar-sweetened drinks, and saturated and trans fats with worse. The authors' conclusion models the honesty this article is about: "observational studies may prove associations but not causation," and the findings need confirmation "especially with well-designed RCTs" (Salas-Huetos et al., 2017). A 2023 meta-analysis did find higher Mediterranean adherence associated with roughly 2.5- to 2.9-fold higher odds of normal sperm concentration and count, but with high between-study heterogeneity and a stated conclusion that the evidence remains insufficient for firm clinical application (Muffone et al., 2023).
One practical note: sperm are produced over roughly 74 days, so the sperm present at retrieval or conception reflect the preceding two-to-three months — the logic behind giving male partners their own 74-day preparation window.
Why might a Mediterranean diet plausibly help? The mechanisms
Observational associations become more believable when a coherent biological story sits underneath. For the Mediterranean pattern, there are five.
Insulin sensitivity. Ovulation is exquisitely sensitive to insulin signaling; hyperinsulinemia drives ovarian androgen production and disrupted follicle development, most visibly in PCOS. The Chavarro cohort's protective pattern was explicitly built around low-glycemic carbohydrates and fat quality (Chavarro et al., 2007), and Mediterranean-style eating is one of the better-studied dietary approaches to improving insulin sensitivity.
Oxidative stress. Both oocytes and sperm are vulnerable to oxidative damage; sperm DNA fragmentation in particular is linked to it. The Mediterranean pattern delivers a steady supply of food-based antioxidants — vitamins C and E, carotenoids, polyphenols — which the male-fertility literature repeatedly flags as correlated with better semen parameters (Salas-Huetos et al., 2017). Food sources are not the same claim as high-dose antioxidant supplements, where evidence is far more mixed (Gaskins & Chavarro, 2018).
Inflammation. Chronic low-grade inflammation is implicated in ovulatory dysfunction, endometrial receptivity problems, and PCOS. The Mediterranean diet is among the best-characterized anti-inflammatory dietary patterns — the explicit rationale the PCOS researchers below give for studying it (Barrea et al., 2019).
Omega-3 fatty acids. Fish is a defining feature of the pattern. Long-chain omega-3s are structural components of cell membranes — including sperm membranes — and Gaskins and Chavarro concluded they "appear to improve female fertility," while noting the open question of whether contaminants in some fish blunt the benefit (2018).
Folate and B vitamins from food. This mechanism has the most direct biomarker evidence in a fertility population: in the Rotterdam couples, Mediterranean-pattern adherence correlated with higher red blood cell folate and higher vitamin B6 in blood and in follicular fluid — the fluid that bathes the developing egg (Vujkovic et al., 2010). Folate's role in one-carbon metabolism makes this a credible pathway, and supplemental folic acid has some of the most consistent evidence in the entire diet-and-fertility literature (Gaskins & Chavarro, 2018). None of this is dosing advice — supplementation decisions belong with your clinician — but it explains why a folate-rich food pattern is biologically sensible.
What about PCOS specifically?
Women with PCOS are heavily targeted by diet marketing, so it is worth stating what the evidence actually is. An Italian case-control study compared 112 treatment-naïve women with PCOS against 112 healthy women matched for age and BMI. The PCOS group showed lower Mediterranean adherence — less olive oil, legumes, fish, and nuts — and, after adjusting for BMI and energy intake, lower adherence correlated with higher testosterone levels and greater clinical severity (Barrea et al., 2019).
Read that design carefully: it is cross-sectional. It cannot tell us whether low adherence worsens PCOS, whether PCOS-related metabolic changes shift food choices, or whether both track something else. What it does support is plausibility: PCOS involves insulin resistance, inflammation, and hyperandrogenism, and the Mediterranean pattern plausibly touches all three. Diet is one lever among several — we cover the fuller picture in our guide to PCOS preparation before IVF.
What doesn't the evidence show?
This section is the reason this article exists. Here is what you cannot honestly claim from the research above.
It does not show causation. Nearly every study cited here is observational. People who score high on Mediterranean adherence differ systematically from people who score low — in income, education, activity, smoking, stress, and things no questionnaire captures. Researchers adjust for the confounders they measured; they cannot adjust for the rest.
RCT evidence is close to absent. No large randomized trial has assigned couples to a Mediterranean diet versus a control diet and followed them to live birth. The 2023 meta-analysis could only pool cohort studies, found high heterogeneity (I² above 80% for the pregnancy outcomes, with confidence intervals crossing 1.0), and concluded the evidence is "insufficient to support their clinical application" (Muffone et al., 2023).
The findings are not uniform. The Greek benefit was absent in women 35 and older (Karayiannis et al., 2018). The Italian cohort found no clear association at all (Ricci et al., 2019). The EARTH cohort found a threshold rather than a dose-response, and a different pattern beat the Mediterranean score outright — leading its authors to caution that Mediterranean-diet advice "may not provide the most appropriate guidance" for US women in treatment (Gaskins et al., 2019). A literature this young should be expected to disagree with itself. It does.
Publication bias is a live concern. Small cohort studies with positive findings are easier to publish than null ones. We know about Ricci's null result because a strong group ran a large study; we do not know how many smaller null analyses were never written up. Treat published effect sizes as optimistic upper estimates.
It does not promise outcomes for any individual. Group-level associations — even real, causal ones — say nothing certain about one person's cycle. Diet does not treat blocked tubes, severe male-factor infertility, or the chromosomal effects of oocyte aging. Anyone who conceived while eating poorly, or didn't while eating perfectly, has simply illustrated how many variables are in play.
If it's not proven, why adopt it for the 90-day pre-cycle window?
Because "unproven as a treatment" and "not worth doing" are different claims, and the decision math is unusually favorable.
The direction of evidence is consistent, and the downside is minimal. When multiple imperfect studies point the same way, the mechanisms are plausible, and the intervention is safe, affordable, and independently good for cardiometabolic health, the rational default is to adopt it while holding the uncertainty honestly. We would not apply this reasoning to an expensive supplement stack or an intervention with real risks.
The timing has a biological rationale. The follicle that releases an egg undergoes its final ~90 days of maturation before ovulation or retrieval, and sperm are produced over roughly 74 days. Whatever influence diet has on gametes operates across that window — which is why we frame preparation as a roughly 90-day project before retrieval, not a week-of scramble.
It is a both-partners pattern. The Rotterdam study associated the couple's adherence with pregnancy odds (Vujkovic et al., 2010), and the male semen-quality data is at least as consistent as the female outcome data. A shared eating pattern is also far easier to sustain than one partner eating separately.
Perfection appears unnecessary. The EARTH data suggested most of the benefit came from not being in the lowest adherence group (Gaskins et al., 2019). That argues for a relaxed, food-based version — vegetables and legumes most days, fish a couple of times a week, olive oil as the main fat, fewer ultra-processed foods — rather than an anxious pursuit of a perfect score. Nutrition stress is not a fertility input anyone needs.
What we do with this
In my practice, the Mediterranean pattern is the default dietary foundation for both partners in the pre-cycle window — presented exactly as the evidence supports it: a reasonable bet with consistent observational backing, not a guarantee and not a therapy. We layer it into a broader 90-day plan alongside sleep, movement, and stress physiology, and every medical and supplement decision stays with your physician and, ideally, a registered dietitian. To see where diet fits for you, start here:
Take the Clarity Check →
Book a free 15-minute call →
References
- Vujkovic M, de Vries JH, Lindemans J, et al. The preconception Mediterranean dietary pattern in couples undergoing in vitro fertilization/intracytoplasmic sperm injection treatment increases the chance of pregnancy. Fertility and Sterility. 2010;94(6):2096-2101. https://pubmed.ncbi.nlm.nih.gov/20189169/
- Karayiannis D, Kontogianni MD, Mendorou C, Mastrominas M, Yiannakouris N. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Human Reproduction. 2018;33(3):494-502. https://pubmed.ncbi.nlm.nih.gov/29390148/
- Karayiannis D, Kontogianni MD, Mendorou C, Douka L, Mastrominas M, Yiannakouris N. Association between adherence to the Mediterranean diet and semen quality parameters in male partners of couples attempting fertility. Human Reproduction. 2017;32(1):215-222. https://pubmed.ncbi.nlm.nih.gov/27994040/
- Salas-Huetos A, Bulló M, Salas-Salvadó J. Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review of observational studies. Human Reproduction Update. 2017;23(4):371-389. https://pubmed.ncbi.nlm.nih.gov/28333357/
- Gaskins AJ, Chavarro JE. Diet and fertility: a review. American Journal of Obstetrics and Gynecology. 2018;218(4):379-389. https://pubmed.ncbi.nlm.nih.gov/28844822/
- Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstetrics & Gynecology. 2007;110(5):1050-1058. https://pubmed.ncbi.nlm.nih.gov/17978119/
- Ricci E, Bravi F, Noli S, et al. Mediterranean diet and outcomes of assisted reproduction: an Italian cohort study. American Journal of Obstetrics and Gynecology. 2019;221(6):627.e1-627.e14. https://pubmed.ncbi.nlm.nih.gov/31288008/
- Gaskins AJ, Nassan FL, Chiu YH, et al.; EARTH Study Team. Dietary patterns and outcomes of assisted reproduction. American Journal of Obstetrics and Gynecology. 2019;220(6):567.e1-567.e18. https://pubmed.ncbi.nlm.nih.gov/30742825/
- Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019;11(10):2278. https://pubmed.ncbi.nlm.nih.gov/31547562/
- Muffone ARMC, de Oliveira Lübke PDP, Rabito EI. Mediterranean diet and infertility: a systematic review with meta-analysis of cohort studies. Nutrition Reviews. 2023;81(7):775-789. https://pubmed.ncbi.nlm.nih.gov/36346903/
Frequently Asked Questions
How long before IVF should I start a Mediterranean diet?
There is no trial-tested answer, but the biology of egg and sperm development suggests a window of roughly 90 days: final follicle maturation takes about three months, and sperm production about 74 days. Studies measured habitual diet rather than a start date, so the honest advice is to begin as early as practical and discuss timing with your fertility clinician.
Can the Mediterranean diet cure infertility or replace IVF?
No. The supporting research is observational — associations, not proven cause and effect — and diet cannot address causes such as blocked tubes, severe male-factor issues, or chromosomal changes from oocyte aging. It is best understood as a low-risk foundation that may support fertility alongside, not instead of, medical evaluation and treatment.
Should the male partner follow the diet too?
The evidence suggests it is reasonable. Cross-sectional research found men with the lowest Mediterranean adherence had roughly 2.6 times higher odds of abnormal sperm concentration, count, and motility, and the one study that scored couples together linked joint adherence to higher pregnancy odds. That cannot prove causation, but since the pattern is safe and heart-healthy, both partners adopting it is a sensible default.
This article is for general education only and is not medical, dietetic, or nutritional advice; please consult your physician or a registered dietitian about your individual situation.